Press releases | WebDisclosure

PRESS RELEASE

published on 09/08/2026 at 07:30, 2 months 3 days ago

Transgene étend son partenariat stratégique avec ProBioGen par un nouvel accord de licence pour la lignée cellulaire AGE1.CR.pIX
Transgene et ProBioGen étendent leur partenariat stratégique avec un nouvel accord de licence pour la lignée cellulaire AGE1.CR.pIX, augmentant les capacités de production et favorisant l'efficacité et la productivité

Partenariat Production Accord De Licence Transgene ProBioGen
PRESS RELEASE

published on 09/08/2026 at 07:30, 2 months 3 days ago

Informations privilégiées / Autres communiqués
GenSight Biologics fait un point sur ses activités de fabrication, cliniques et financières, confirmant la date de publication des comptes semestriels 2026

Fabrication GenSight Biologics Thérapies Géniques Comptes Semestriels Actifs Cliniques
PRESS RELEASE

published on 09/08/2026 at 07:30, 2 months 3 days ago

Inside Information / Other news releases
GenSight Biologics provides business updates on manufacturing, clinical activities, and financial status for September 2026, including progress on gene therapy treatments

Financial Updates Manufacturing Business Updates Clinical Activities GenSight Biologics
PRESS RELEASE

published on 09/08/2026 at 07:30, 2 months 3 days ago

Informations privilégiées / Autres communiqués
Annulation par MEMSCAP de 105 483 actions, soit 1,37% du capital, acquises dans le cadre de son programme de rachat d'actions. Réduction du capital social

Conseil D'administration Capitaux Annulation MEMSCAP Compte
PRESS RELEASE

published on 09/08/2026 at 07:30, 2 months 3 days ago

Inside Information / Other news releases
MEMSCAP announces the cancellation of 105,483 shares, representing 1.37% of its share capital, acquired under its share buyback program. Reduction results in a nominal reduction in share capital of EUR 26,370.75

Share Buyback Program Share Cancellation Financial Restructuring Share Capital Reduction MEMSCAP
PRESS RELEASE

published on 09/08/2026 at 07:05, 2 months 3 days ago

Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity
Sandoz announces USD 300 million investment in new drug substance facility in Ljubljana, Slovenia, to enhance biosimilar manufacturing capacity and support Bio100 goal

Manufacturing Investment Biosimilar Sandoz Facility
PRESS RELEASE

published on 09/08/2026 at 07:00, 2 months 3 days ago

Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars
Sandoz hosts Capital Markets Day unveiling Bio100 ambition to maximize value in golden decade for biosimilars. Strong growth plan aims for 100+ biosimilars by 2040

Growth Strategy Biosimilars Capital Markets Day Sandoz Bio100 Ambition
PRESS RELEASE

published on 09/08/2026 at 07:00, 2 months 3 days ago

Newron reports subscription for EUR 5.5 million of shares by investor group as part of up to EUR 38 million total financing to advance Phase 3 evenamide program
Newron Pharmaceuticals S.p.A. secures EUR 5.5 million from investor group to advance Phase 3 evenamide program, with total financing of up to EUR 38 million

Newron Pharmaceuticals Phase 3 Investor Group EUR 5.5 Million Evenamide Program
PRESS RELEASE

published on 09/08/2026 at 06:30, 2 months 3 days ago

Ad hoc announcement pursuant to Art. 53 LR News Release
Oerlikon announces Mission 2030 financial targets: Sales over CHF 2 billion, EBITDA margin above 20%, ROCE over 10% by 2030. Details on strategy and growth provided at Capital Markets Day 2026

Growth Opportunities Financial Targets Capital Markets Day Oerlikon Mission 2030
PRESS RELEASE

published on 09/08/2026 at 06:20, 2 months 3 days ago

Guanlan AI Applications: Higher Accuracy, Lower Cost, Smarter Interaction
Hikvision launches Guanlan AI Applications for higher accuracy, lower cost, and smarter interaction, enhancing video systems with AI detection, analysis, and efficiency features

AI Detection Hikvision Guanlan AI Applications Video Systems Natural Language Innovations

Published on 11/12/2026 at 01:40, 13 minutes ago

Nexteer Announces First Share Repurchase Programme of Up to US$60 Million
Published on 11/11/2026 at 23:30, 2 hours 23 minutes ago

Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 2 hours 48 minutes ago

Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 2 hours 53 minutes ago

CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 3 hours 23 minutes ago

55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website

View all ACCESSWIRE

Published on 11/11/2026 at 19:29, 6 hours 24 minutes ago

EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 7 hours 11 minutes ago

AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/11/2026 at 18:37, 7 hours 15 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:36, 7 hours 16 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:35, 7 hours 17 minutes ago

Holding(s) in Company

View all EQS

Published on 11/10/2026 at 18:00, 1 day 7 hours ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 8 hours ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 1 day 8 hours ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 1 day 8 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 8 hours ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE

News